Back to TARS
Paradigm Biocapital Advisors LP → TARS
Paradigm Biocapital Advisors LP TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$180.9M
Q3 2026
Peak value
$209.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $209.8M |
| Q1 2026 | $179.7M |
| Q2 2026 | $174.7M |
| Q3 2026 | $180.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $180.9M | 2.30M | — | — |
| Q2 2026 | $174.7M | 2.78M | — | — |
| Q1 2026 | $179.7M | 2.56M | — | — |
| Q4 2025 | $209.8M | 2.56M | — | — |
Other funds holding TARS
$299.3M
$273.9M
$273.1M
$252.5M
$234.7M
$230.8M
$220.2M